Results 101 to 110 of about 138,715 (220)

Risk factors associated with age-related macular degeneration [PDF]

, 2000

openalex   +1 more source

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration [PDF]

, 2000
Maki Honda, Taiji Sakamoto, Tatsuro Ishibashi, H Inomata, Hiroo Ueno   +4 more
openalex   +1 more source

Molecular Genetics of Age-related Macular Degeneration [PDF]

, 2008
Age-related macular degeneration (AMD; OMIM # 603075) is an eye disease of the elderly, signs of which appear after the age of 50. In the Western world it is a leading cause of permanent visual loss with a prevalence of 8.5% in persons under 54 years of ...
Seitsonen, Sanna
core  

Age-related macular degeneration [PDF]

, 2017
Senilna makularna degeneracija je vodeći uzrok sljepoće starijeg stanovništva u razvijenim zemljama svijeta. Prvenstveno rezultira gubitkom centralnoga vida.
Milošević, Ana
core   +4 more sources

Genetic Insights into Age-Related Macular Degeneration

Biomedicines
One of the major causes of vision impairment among elderly people in developed nations is age-related macular degeneration (AMD). The distinctive features of AMD are the accumulation of extracellular deposits called drusen and the gradual deterioration ...
Bhumika, Nalini S. Bora, Puran S. Bora
doaj   +1 more source

Targeted Therapy on Age-Related Macular Degeneration

TNOA Journal of Ophthalmic Science and Research
Age-related macular degeneration (AMD) is an eye-related condition in developed countries and can affect elderly individuals to lose their central vision.
Vankodoth Sireesha, Kaluvala Ramya, Manne Nikshitha, Sunkari Nikitha, T. Rama Rao   +4 more
doaj   +1 more source

Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration [PDF]

, 2000
Franziska Krämer, Karen L. White, Daniel Pauleikhoff, Andrea Gehrig, Lori A. Passmore, Andrea Rivera, Günther Rudolph, Ulrich Kellner, Monika Andrassi, Birgit Lorenz, Klaus Rohrschneider, A. Blankenagel, Bernhard Jurklies, H Schilling, F. Schütt, Frank G. Holz, Bernhard H. F. Weber   +16 more
openalex   +1 more source

Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation [PDF]

, 2000
B. A. Lafaut
openalex   +1 more source

Radiotherapy for age related macular degeneration causes transient lens transparency changes [PDF]

, 2000
Nicole Eter
openalex   +1 more source

What’s new in age-related macular degeneration?

Community Eye Health Journal, 2006
Introduction Age-related macular degeneration (AMD) was regarded as unimportant in global blindness, of relevance only to the minority of the world’s population that live in wealthy countries. However, increasing life expectancy, particularly in Asia,
David Yorston
doaj